Status
Conditions
Treatments
About
This survey will allow to identify PE prognostic, but also long-term complications, i.e. recurrence rate, on-treatment bleedings, deep-vein thrombosis sequella, pulmonary hypertension rate, and chronic pulmonary disease rate without PH. This database should help us identify risk-factors for each event.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
547 participants in 2 patient groups
Loading...
Central trial contact
emile Ferrari, PUPH; Amina Zamii-Smondel
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal